Evidence review
Compounded Semaglutide and Tirzepatide Dosage: Starting Doses, Steps and Units
The FDA-label starting doses and step-ups for semaglutide and tirzepatide, why syringe units depend on your vial, and what to confirm with your pharmacist.
On this page
Your dose is the one your prescriber wrote and your dispensing pharmacist labeled, not a number from a chart online. What a chart can do is show you the schedule the approved versions of the same molecules follow, so you know what a prescription is usually measured against and what questions to ask. Both approved schedules below start low and rise in four-week steps, and both labels say the steps exist to reduce gastrointestinal side effects.1, 2
This guide deliberately gives no conversion from milligrams to syringe units. The reason is in FDA's own reports: patients and clinicians who did that arithmetic for compounded semaglutide produced doses five to 20 times what was intended, and some people were hospitalized.3 The label schedules were read from the current U.S. prescribing information on November 20, 2026.
The approved semaglutide schedule
Wegovy injection starts at 0.25 mg once a week and steps up every four weeks until the maintenance dose. The label sets that schedule for every approved use in adults and in children aged 12 and older.1
| Weeks | Once-weekly Wegovy injection |
|---|---|
| 1 through 4 | 0.25 mg (starting dose) |
| 5 through 8 | 0.5 mg |
| 9 through 12 | 1 mg |
| 13 through 16 | 1.7 mg |
| 17 onward | Maintenance: 2.4 mg recommended, or 1.7 mg |
For weight reduction in adults, the June 2026 label adds a higher step. A patient who has tolerated 2.4 mg for at least four weeks, and for whom more weight loss is clinically indicated, may be increased to a maximum of 7.2 mg once a week. If a dose is not tolerated during the climb, the label suggests delaying the next step by four weeks.1
Wegovy also comes as a daily tablet, which has its own schedule: 1.5 mg for the first 30 days, then 4 mg, then 9 mg, then a 25 mg maintenance dose from day 91.1 Those tablet strengths are not interchangeable with weekly injection doses. Our oral versus injectable comparison covers the practical differences between the two forms, including how the tablet has to be taken.
The approved tirzepatide schedule
Zepbound starts at 2.5 mg once a week for four weeks. The label is explicit that 2.5 mg is a starting dose only and is not approved for maintenance.2
| Step | Once-weekly Zepbound injection |
|---|---|
| Weeks 1 through 4 | 2.5 mg (starting dose only) |
| From week 5 | 5 mg |
| Each later step | Up 2.5 mg, after at least 4 weeks on the current dose |
| Maintenance for weight reduction | 5 mg, 10 mg or 15 mg |
| Maintenance for obstructive sleep apnea | 10 mg or 15 mg |
| Maximum for any use | 15 mg |
The prescriber chooses the maintenance dose by response and tolerability, and the label allows a lower maintenance dose if one is not tolerated.2 For people using Zepbound vials, the label tells patients to use a syringe suited to the dose, such as a 1 mL syringe that can measure 0.5 mL or 0.6 mL, and a new syringe and needle every time.2
Missed doses follow different rules
The two labels handle a missed injection differently, which is one more reason not to borrow one product's instructions for another. For Zepbound, a missed dose can be taken within four days (96 hours); after that it is skipped and the regular day resumes.2 For Wegovy injection, a missed dose is taken as soon as possible only if the next one is more than two days away; otherwise it is skipped. Missing two or more doses in a row means restarting the escalation at a lower dose.1 Ask your prescriber which rule applies to a compounded prescription before you need it.
If you are choosing a seller, our bmiMD review, our Live Vital review, and our ShedRx review set out the prices, renewal terms and what we could not verify for each. All of these sellers pay us a commission when a reader signs up, which never changes a grade.
What compounded prescriptions change
A compounded preparation is not an approved product, and FDA does not review it for safety, effectiveness or quality before it is sold.3 The molecule can be the same while the container, concentration and directions differ. FDA notes that compounders sell semaglutide in multiple-dose vials and prefilled syringes, that concentrations vary by compounder, and that one compounder may offer several concentrations.3 Our compounded versus brand-name guide explains what else differs, including added ingredients and how the preparations are made.
So the same "starting dose" in milligrams can arrive as very different volumes in two households. A prescription that follows the label schedule in milligrams still has to be translated into a volume from your particular vial, and that translation belongs to the prescriber and pharmacist who know the concentration.
Why "units" cannot be read off a chart
On a U-100 insulin syringe, the markings measure volume: FDA's own example describes a 5-unit dose as 0.05 mL on a 1 mL syringe.3 How much semaglutide or tirzepatide sits in those 5 units depends entirely on the concentration of the liquid in your vial. Two vials with different concentrations put different doses in the same number of units, which is why a units chart published for one pharmacy's vial can be wrong for yours.
FDA's dosing-error reports show how this goes wrong in practice. Most described patients drawing more than the prescribed dose from a multiple-dose vial, including people told to draw 5 units who drew 50. Clinicians also miscalculated: one intended 0.25 mg, which was 5 units for that vial, and prescribed 25 units. In one case a patient who could not get clear instructions from the prescribing telehealth company searched online for dosing advice and took five times the intended dose.3
The vial-label guide shows where the concentration, total volume and directions sit on the packaging, so you can point to them when you ask. If you are comparing sellers, the best compounded tirzepatide list and the tirzepatide cost page show what each one charges, but a price per vial says nothing about the dose in it until you know the concentration.
What to confirm before the first injection
Ask the dispensing pharmacist, in writing if you can, to answer these together rather than one at a time:
- The prescribed dose in milligrams, and the concentration of this vial in mg/mL.
- The volume to draw for that dose, and the syringe it should be measured with.
- Whether the supplied syringe matches those directions, and what to do if it does not.
- When the dose steps up, and whether the next step comes with a new vial or new directions.
- How long the vial can be used after the first puncture, and how it should be stored.
FDA encourages prescribers and compounders to supply a syringe sized for the dose and to show patients how to measure it.3 If any of those answers conflict, or arrive only from a billing or customer-service desk, ask for the pharmacist. When a shipment arrives warm or late, the warm-shipment checklist covers what to document before the dose question even comes up.
Each new vial is a new check
A refill can come at a different concentration from the last vial even when the milligram dose is unchanged, and an old instruction in units would then be wrong. Compare each new label with the previous one before using it. This matters most when you switch GLP-1 providers, because the new pharmacy's vial may not match the old one. Our compounded semaglutide safety guide covers the wider questions about the pharmacy itself.
Send the pharmacy something like: "Please confirm my prescribed dose in mg, this vial's concentration, the volume to draw, and the syringe to use. My previous vial was [concentration]; tell me if anything changed." Keep the written reply with the vial, and treat any instruction you cannot reconcile as a question for the pharmacist rather than a sum to work out yourself.
Frequently asked questions
What is the starting dose of compounded tirzepatide?
Your prescriber sets it. For comparison, the approved Zepbound label starts at 2.5 mg once a week for four weeks, then 5 mg, and says 2.5 mg is a starting dose only, not a maintenance dose.
What is the starting dose of compounded semaglutide?
Your prescriber sets it. The approved Wegovy injection label starts at 0.25 mg once a week for four weeks and steps up every four weeks through 0.5 mg, 1 mg and 1.7 mg to a 2.4 mg or 1.7 mg maintenance dose.
How many units is my compounded dose?
That depends on the concentration of your vial, so no general chart can answer it. Ask the dispensing pharmacist to confirm the dose in mg, the vial's concentration, the volume to draw and the syringe to use. FDA has reported hospitalizations from errors converting milligrams to units.
What is the maintenance dose of tirzepatide?
On the Zepbound label, 5 mg, 10 mg or 15 mg once a week for weight reduction, and 10 mg or 15 mg for obstructive sleep apnea. The maximum for any use is 15 mg a week.
References
- Novo Nordisk (2026). Wegovy prescribing information, revised June 2026. Novo Nordisk. Read source
- Eli Lilly and Company (2026). Zepbound U.S. prescribing information, revised November 2026. Eli Lilly and Company. Read source
- U.S. Food and Drug Administration (2024). FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. FDA. Read source
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Continue reading
Compounded GLP-1 Vial Labels: What mg, mL and Units Mean
Understand the fields on a compounded GLP-1 vial label, identify unclear instructions and ask your pharmacist about concentration, units and beyond-use dates.
ReadHow Long Compounded Tirzepatide and Semaglutide Last: Fridge, Room Temperature and the 28-Day Rule
How long a compounded GLP-1 vial lasts in or out of the fridge depends on its own label. What the brand labels allow, and FDA's 28-day rule after first use.
ReadGide Health Review: Injection Prices and Refund Cutoffs
What Gide Health’s two starting prices cover and what to confirm about the prescription and refund cutoff.
ReadAJ Peptide Review: Promotional Prices and Renewal
What AJ Peptide’s GLP-1 price cards show and what to confirm before the next charge.
ReadBestDaysRx Review: What Does a 30-Day Order Cost?
BestDaysRx lists different prices by strength for 30 days of compounded tirzepatide with B12. Check the repeat price and what happens if an order is canceled.
ReadCeliaRx Review: Vial Prices, Consultation and Refunds
CeliaRx lists vial prices and monthly figures. See what to confirm about the amount due, included supply and membership terms.
Read